Tissue-, Blood-, and Urine-Based Proteomics Changes of Different Endometrial Receptivity Status in Patients after Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia or Endometrial Cancer
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Tao Tao und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospita…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Endometrial Hyperplasia, Proteomics, Endometrium. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National High-Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Liquid biopsy noninvasively characterizes diseases by analyzing biomarker proteins in biofluids, which provide valuable insights into physiological and pathological processes. In this study, we conducted an analysis of the differences between atypical endometrial hyperplasia or endometrial cancer (AH/EC) patients after fertility-sparing treatment with different RNA-Seq-based endometrial receptivity test (rsERT) results ("receptive" versus "pre-receptive"), to investigate the proteomic connections among tissue, serum, and urine samples. Samples of endometrial tissue, serum, and urine from 40 rsERT "pre-receptive" and 10 rsERT "receptive" patients were analyzed for proteomic profiling. We integrated differentially expressed proteins from three sample types to investigate endometrial receptor (ER)-related molecular changes. Our findings indicated that both serum and urine proteomes can serve as indicators of functional changes in endometrial tissue. In serum, proteins associated with cholesterol metabolism, immune response, and coagulation exhibited a differential expression. In urine, proteins related to immune function and metabolic processes demonstrated varying levels of expression. The differentially expressed proteins in both serum and urine were associated with the immune response and metabolism. In conclusion, biofluids serve as a reflection of functional changes in endometrial tissue, which will facilitate a deeper understanding of endometrial receptivity and the discovery of potential clinical biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Obstetric & Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,…
- Core Instrument Facility, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China.
ORCID-Profile: Xiaoping Xiao, Wei Sun
Förderung
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Tao, T., Xiao, X., Zhou, Y., Sun, H., Liu, X., Sun, W., Guo, Z., & Deng, C. (2025). Tissue-, Blood-, and Urine-Based Proteomics Changes of Different Endometrial Receptivity Status in Patients after Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia or Endometrial Cancer. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00315
Vancouver
Tao T, Xiao X, Zhou Y, Sun H, Liu X, Sun W, et al. Tissue-, Blood-, and Urine-Based Proteomics Changes of Different Endometrial Receptivity Status in Patients after Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia or Endometrial Cancer. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00315
BibTeX
@article{Tao2025,
author = {Tao, Tao and Xiao, Xiaoping and Zhou, Yuanzheng and Sun, Haidan and Liu, Xiaoyan and Sun, Wei and Guo, Zhengguang and Deng, Chengyan},
title = {Tissue-, Blood-, and Urine-Based Proteomics Changes of Different Endometrial Receptivity Status in Patients after Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia or Endometrial Cancer},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00315}
}
EUVIMED